The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Accepted for Priority Review Elinzanetant (Bayer) A dual neurokinin-1 and 3 receptor antagonist Treatment of moderate to severe vasomotor symptoms caused by adjuvant endocrine therapy in women ...

Panelists discuss how step-up dosing protocols reduce cytokine release syndrome (CRS) risk in patients with high-risk disease and when modifications might be necessary as well as the incorporation ...

Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in the OASIS 4 trial.

Champions League highlights: Bayer Leverkusen 2-0 Sparta Prague Bayer Leverkusen secured their place in the last 16 of the Champions League with a routine victory over Sparta Prague at the BayArena.

Bayer Leverkusen have held talks with Manchester City over a deal for James McAtee. The Bundesliga side, who have also approached Aston Villa over a loan move for Emiliano Buendia, had pinpointed ...

FEZOLINETANT and elinzanetant were both effective and safe in reducing vasomotor symptoms in menopausal women, with elinzanetant offering additional benefits for sleep quality and fewer adverse events ...

Leeds United transfer target James McAtee is wanted by Bundesliga champions Bayer Leverkusen, it has been reported. The Whites, who have been linked with a move for the 22-year-old since the summer, ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic breast cancer who had progressed on multiple line of therapy. CDK4/6 inhibitors ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Marco Rose Formation: 4 - 4 - 2 Manager: Xabi Alonso Formation: 4 - 2 ...